A group of bioengineers have developed a noninvasive, portable device that resembles a finger-worn, pulse oximeter to count white blood cells. They have three workable prototypes that are being tested with chemotherapy patients to track their immune system in real-time. The researchers aim to have an initial beta product that it can support via crowdfunding in 2017, with a product on the market potentially in 2019.
UVLrx Therapeutics has secured a CE mark for its intravenous UV light therapeutic system across a wide variety of indications. The use of ultraviolet blood irradiation stretches back over a century, but fell out of favor with the rise of antibiotics in the 1950s. This system, dubbed UVLrx 1500, is designed to be used without removing the blood from the body.
A compound derived from soybeans and other plants may have HIV-fighting properties, according to new research by scientists at George Mason University.
It's not quite the fountain of youth, but scientists with the Stanford University School of Medicine are zeroing in on a potential protein target that could at least help us age better. By blocking it with a potential new compound, they believe that they can stop age-related immune system declines and many of the diseases that come with this.
Researchers at Australia's Burnet Institute discovered a prime target in the immune system's battle against malaria, marking a turning point in the search for a vaccine.
Today, we're one small but significant step closer to figuring out how to get certain cells to fight back against HIV infection. Specifically, scientists with the NYU Langone Medical Center and
In the bid to develop drugs to boost the immune system and fend off various infections, NKp46 may be the next big target. NKp46 is a receptor that helps regulate the immune system's natural killer
When the body is under attack from an infection, the immune system develops memory T cells that help remember and attack the disease if it returns. But with chronic viruses like HIV or hepatitis C,
Researchers at Emory University have used one of the most successful vaccines, yellow fever, to promote longer-lasting immunity for vaccine recipients. And their discoveries could lead to fewer
After 10 years of lab work a team of German scientists say they have developed a transgenic mouse model with modified T cell receptors that can help the immune system hunt down and destroy cancer